Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Weinshenker

Showing results (1-10 of 225) with videos related to

Pageof 23
Sort By:
Rinsho Shinkeigaku = Clinical Neurology|December 25, 2009
[Rescue treatments for multiple sclerosis]Brian G Weinshenker
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2012
Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: noBrian G Weinshenker
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2024
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: CommentaryBrian G Weinshenker
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?Brian G Weinshenker
Annals of Internal Medicine|March 19, 2014
Review: in relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse ratesBrian G Weinshenker
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Placebo Studies should not be Undertaken in Neuromyelitis Optica: CommentaryBrian G Weinshenker
Lancet (London, England)|March 22, 2003
Neuromyelitis optica: what it is and what it might beBrian G Weinshenker
ACP Journal Club|May 5, 2004
Cannabinoids did not reduce muscle spasticity in stable multiple sclerosisBrian G Weinshenker
ACP Journal Club|September 2, 2006
Review: magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosisBrian G Weinshenker
Evidence-Based Medicine|January 11, 2007
Review: magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosisBrian G Weinshenker
Pageof 23

Showing results (1-10 of 225) with videos related to

Sort By:
Pageof 23
Rinsho Shinkeigaku = Clinical Neurology|December 25, 2009
[Rescue treatments for multiple sclerosis]Brian G Weinshenker
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2012
Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: noBrian G Weinshenker
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2024
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: CommentaryBrian G Weinshenker
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?Brian G Weinshenker
Annals of Internal Medicine|March 19, 2014
Review: in relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse ratesBrian G Weinshenker
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Placebo Studies should not be Undertaken in Neuromyelitis Optica: CommentaryBrian G Weinshenker
Lancet (London, England)|March 22, 2003
Neuromyelitis optica: what it is and what it might beBrian G Weinshenker
ACP Journal Club|May 5, 2004
Cannabinoids did not reduce muscle spasticity in stable multiple sclerosisBrian G Weinshenker
ACP Journal Club|September 2, 2006
Review: magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosisBrian G Weinshenker
Evidence-Based Medicine|January 11, 2007
Review: magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosisBrian G Weinshenker
Pageof 23